Jamie Clark
Stock Analyst at Rothschild & Co
(2.39)
# 3,029
Out of 5,182 analysts
9
Total ratings
71.43%
Success rate
8.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $292.13 | +6.46% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $409.65 | +15.71% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $102.49 | +130.27% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $166.79 | +9.12% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $259.57 | +6.33% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $195.05 | -0.03% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $158.98 | +73.61% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $292.13
Upside: +6.46%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $409.65
Upside: +15.71%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $102.49
Upside: +130.27%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $166.79
Upside: +9.12%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $259.57
Upside: +6.33%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $195.05
Upside: -0.03%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $158.98
Upside: +73.61%